冠科美博(Apollomics Inc.)宣布完成和SPAC Maxpro合并,并在纳斯达克上市 Mar 30, 2023 20:31 HKT | ![Apollomics,](http://www.acnnewswire.com/images/toppage/Apollomics65.jpg) |
|
冠科美博(Apollomics Inc.)宣佈完成和SPAC Maxpro合併,並在納斯達克上市 Mar 30, 2023 20:30 HKT | ![Apollomics,](http://www.acnnewswire.com/images/toppage/Apollomics65.jpg) |
|
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq Mar 30, 2023 20:29 HKT | ![Apollomics,](http://www.acnnewswire.com/images/toppage/Apollomics65.jpg) |
|
Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing Mar 21, 2023 08:30 HKT | ![Cryoviva](http://www.acnnewswire.com/images/toppage/cryovivalogo68.jpg) |
|
亿胜生物公布2022年度业绩 Mar 08, 2023 20:30 HKT | ![Essex](http://www.acnnewswire.com/images/toppage/Essexbio.68.jpg) |
|
億勝生物公布2022年度業績 Mar 08, 2023 20:29 HKT | ![Essex](http://www.acnnewswire.com/images/toppage/Essexbio.68.jpg) |
|
Essex Bio-Technology Announces 2022 Annual Financial Results Mar 08, 2023 20:28 HKT | ![Essex](http://www.acnnewswire.com/images/toppage/Essexbio.68.jpg) |
|
“天然分子” 的葫蘆裡,給慢病埋的什麼藥? Mar 03, 2023 09:48 HKT | |
|
“天然分子” 的葫芦里,给慢病埋的什么药? Mar 03, 2023 09:47 HKT | |
|
亿胜生物与复宏汉霖签订治疗年龄相关性黄斑变性全球共同开发及独家许可协议之经修订协议 Feb 22, 2023 18:50 HKT | ![Essex](http://www.acnnewswire.com/images/toppage/Essexbio.68.jpg) |
|
億勝生物與復宏漢霖簽訂治療年齡相關性黃斑變性全球共同開發及獨家許可協議之經修訂協議 Feb 22, 2023 18:49 HKT | ![Essex](http://www.acnnewswire.com/images/toppage/Essexbio.68.jpg) |
|
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration Feb 22, 2023 18:48 HKT | ![Essex](http://www.acnnewswire.com/images/toppage/Essexbio.68.jpg) |
|
疫苗开发不断变化的全球格局:Novotech 和 Endpoints News 网络研讨会 Feb 16, 2023 08:00 HKT | ![Novotech](http://www.acnnewswire.com/images/toppage/Novotech.64.jpg) |
|
疫苗開發不斷變化的全球格局:Novotech 和 Endpoints News 網絡研討會 Feb 16, 2023 08:00 HKT | ![Novotech](http://www.acnnewswire.com/images/toppage/Novotech.64.jpg) |
|
백신 개발 발전의 글로벌 환경: 노보텍 및 엔드포인트 뉴스 웨비나 Feb 16, 2023 08:00 HKT | ![Novotech](http://www.acnnewswire.com/images/toppage/Novotech.64.jpg) |
|
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar Feb 15, 2023 09:00 HKT | ![Novotech](http://www.acnnewswire.com/images/toppage/Novotech.64.jpg) |
|
Novotech 全球报告:亚太地区稳健的 1 期试验增长 Feb 13, 2023 06:00 HKT | ![Novotech](http://www.acnnewswire.com/images/toppage/Novotech.64.jpg) |
|
Novotech 全球報告:亞太地區穩健的 1 期試驗增長 Feb 13, 2023 06:00 HKT | ![Novotech](http://www.acnnewswire.com/images/toppage/Novotech.64.jpg) |
|
노보텍 글로벌 보고서: 아시아 태평양 지역에서 1단계 임상시험의 확고한 성장 Feb 13, 2023 06:00 HKT | ![Novotech](http://www.acnnewswire.com/images/toppage/Novotech.64.jpg) |
|
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases Feb 10, 2023 21:06 HKT | ![Essex](http://www.acnnewswire.com/images/toppage/Essexbio.68.jpg) |
|